I. Diterich

Most-cited papers

1. Heterozygous Arg753Gln Polymorphism of Human TLR-2 Impairs Immune Activation by Borrelia burgdorferi and Protects from Late Stage Lyme Disease1

   N. W. Schröder, I. Diterich, A. Zinke, J. Eckert +11 more

   2005Journal of Immunology206 citations Open access

   Semantic Scholar

   Save

2. Distribution of Clinically Relevant Borrelia Genospecies in Ticks Assessed by a Novel, Single-Run, Real-Time PCR

   Caroline Rauter, R. Oehme, I. Diterich, Matthias Engele +1 more

   2002Journal of Clinical Microbiology108 citations Open access

   Semantic Scholar

   Save

3. Borrelia burgdorferi-Induced Tolerance as a Model of Persistence via Immunosuppression

   I. Diterich, Caroline Rauter, C. Kirschning, T. Hartung

   2003Infection and Immunity77 citations Open access

   Semantic Scholar

   Save

4. Critical Evaluation of Urine-Based PCR Assay for Diagnosis of Lyme Borreliosis

   Caroline Rauter, Markus M. Mueller, I. Diterich, S. Zeller +3 more

   2005Clinical Diagnostic Laboratory Immunology54 citations Open access

   Semantic Scholar

   Save

5. Modulation of Cytokine Release in Ex Vivo-Stimulated Blood from Borreliosis Patients

   I. Diterich, L. Härter, Dieter Hassler, A. Wendel +1 more

   2001Infection and Immunity53 citations Open access

   Semantic Scholar

   Save

6. Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.

   U. Halbsguth, K. Rentsch, D. Eich-Höchli, I. Diterich +1 more

   2008British Journal of Clinical Pharmacology31 citations Open access

   Semantic Scholar

   Save

7. Identification of Borrelia burgdorferi Ribosomal Protein L25 by the Phage Surface Display Method and Evaluation of the Protein's Value for Serodiagnosis

   Markus M. Mueller, S. Bunk, I. Diterich, M. Weichel +5 more

   2006Journal of Clinical Microbiology9 citations Open access

   Semantic Scholar

   Save

8. Granulocyte Colony-Stimulating Factor (Filgrastim) Treatment Primes for Increased ex Vivo Inducible Prostanoid Release

   S. von Aulock, E. Boneberg, I. Diterich, T. Hartung

   2004Journal of Pharmacology and Experimental Therapeutics9 citations Open access

   Semantic Scholar

   Save

9. G-CSF: boosting endogenous production--a new strategy?

   S. von Aulock, I. Diterich, L. Hareng, T. Hartung

   2004Current opinion in investigational drugs8 citations

   Semantic Scholar

   Save

10. Human TLR-2 Impairs Immune Activation by Heterozygous Arg753Gln Polymorphism of

    R. Schumann, G. Burmester, U. Göbel, C. Hermann +7 more

    20110 citations

    Semantic Scholar

    Save

11. Erratum: Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease (Journal of Immunology (2005) 175 (2534-2540))

    N. W. Schröder, I. Diterich, A. Zinke, J. Eckert +11 more

    20060 citations

    Semantic Scholar

    Save

12. Junction Proteins Population Expressing Langerin and Tight Integrin-Positive Epithelial Dendritic Cell 7 b )-E a A Major Lung CD103 (

    N. W. Schröder, I. Diterich, A. Zinke, J. Eckert +6 more

    20060 citations

    Semantic Scholar

    Save

13. TOWARDS A METHOD TO DETECT LPS IN PLASMA OF SEPSIS PATIENTS BASED ON MONOCYTE CYTOKINE RELEASE: 413

    Y. Chichkova, A. Günther, I. Diterich, V. Otto +2 more

    20040 citations

    Semantic Scholar

    Save

14. Immunomodulation and new therapeutic strategies in Lyme borreliosis

    I. Diterich

    20030 citations

    Semantic Scholar

    Save